ArticleDiabetology & metabolic syndrome2026

Preoperative empagliflozin and ventricular remodeling after coronary artery bypass grafting in type 2 diabetes: a prespecified analysis of the POST-CABGDM randomized trial.

Vinícius Oro Popp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.